نتایج جستجو برای: transplant lymphoproliferative disorder

تعداد نتایج: 661714  

Journal: :Haematologica 2013
Daan Dierickx Thomas Tousseyn Annelies Requilé Raf Verscuren Xavier Sagaert Julie Morscio Iwona Wlodarska An Herreman Dirk Kuypers Johan Van Cleemput Frederik Nevens Lieven Dupont Anne Uyttebroeck Jacques Pirenne Christiane De Wolf-Peeters Gregor Verhoef Lieselot Brepoels Olivier Gheysens

We investigated sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-fluorodeoxyglucose-positron emission tomography in 170 cases with suspected or biopsy-proven posttransplant lymphoproliferative disorder. All solid organ and hematopoietic stem cell transplant recipients who underwent an 18F-fluorodeoxyglucose-positron emission tomography scan betw...

Journal: :Haematologica 2016
Jan Styczynski Walter van der Velden Christopher P Fox Dan Engelhard Rafael de la Camara Catherine Cordonnier Per Ljungman

Epstein-Barr virus-related post-transplant lymphoproliferative disorders are recognized as a significant cause of morbidity and mortality in patients undergoing hematopoietic stem cell transplantation. To better define current understanding of post-transplant lymphoproliferative disorders in stem cell transplant patients, and to improve its diagnosis and management, a working group of the Sixth...

2016
Neeta Malviya Heather Wickless

We report a case of primary cutaneous CD30+ post-transplant lymphoproliferative disorder with an uncommon finding of signet ring cell features in a heart transplant patient. The neoplastic cells were CD4 and CD30 positive, and negative for S-100, pancytokeratin, myeloperoxidase, and CD56. In situ hybridization for Epstein Barr Virus (EBV) was negative, even though the patient did have EBV viremia.

Journal: :Haematologica 2004
Otávio C G Baiocchi Gisele W B Colleoni Otávia L Caballero André L Vettore Ana Lucia S S Andrade José O M Pestana

Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening Epstein-Barr virus (EBV)-driven B-cell malignancy occurring in 1 to 3% of renal transplant patients. Recently, EBV DNA quantification has become a useful tool for identifying patients at risk of developing PTLD. However, studies on EBV load differ in design, methodology and type of patients.

2014
Brian Hutton Lawrence Joseph Fatemeh Yazdi Jennifer Tetzlaff Mona Hersi Madzouka Kokolo Nicolas Fergusson Alexandria Bennett Chieny Buenaventura Dean Fergusson Andrea Tricco Sharon Strauss David Moher Greg Knoll

BACKGROUND Patients undergoing renal transplant procedures require multi-agent immunosuppressive regimens both short term (induction phase) and long term (maintenance phase) to minimize the risk of organ rejection. There are several drug classes and agents for immunosuppression. Use of these agents may increase the risk of different harms including not only infections, but also malignancies inc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید